GENETIC SIGNATURES LIMITED

INVESTOR PRESENTATION - GENETIC SIGNATURES LIMITED

ASX:GSS

GENETIC SIGNATURES LIMITED

Health Care

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Market Cap

323.73m

Price at Close

$2.27

4w avg. Volume

233.73k

4w avg. Turnover

$591.10k

Announcements
announcementt+2 movementdate
  • Change in substantial holding

    Shareholder Details

  • 0.00%

    07 Aug 2020

0.00%

07 Aug 2020
  • Investor presentation

    Periodic Reports

  • -6.74%

    27 Jul 2020

-6.74%

27 Jul 2020
  • Quarterly report and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • -6.74%

    27 Jul 2020

-6.74%

27 Jul 2020
  • Shares released from voluntary escrow

    Issued Capital

  • -6.10%

    24 Jun 2020

-6.10%

24 Jun 2020
  • Change of Auditor

    Company Administration

  • -3.33%

    17 Jun 2020

-3.33%

17 Jun 2020
  • S&P DJI Announces June 2020 Quarterly Rebalance

    Other · Market sensitive

  • -7.51%

    11 Jun 2020

-7.51%

11 Jun 2020
  • Investor Presentation

    Periodic Reports

  • +2.50%

    28 May 2020

+2.50%

28 May 2020
  • Appendix 2A

    Issued Capital

  • -2.55%

    12 May 2020

-2.55%

12 May 2020
  • Change in substantial holding

    Shareholder Details

  • -3.65%

    10 May 2020

-3.65%

10 May 2020
  • Appendix 4C & quarterly update

    Commitments test entity quarterly reports · Market sensitive

  • +3.16%

    29 Apr 2020

+3.16%

29 Apr 2020
Market Data

Current Price

$2.27

52WK HIGH

$2.94

52WK LOW

$0.9

1YR RETURN

+116.19%

1YR RETURN VS. SECTOR

-45.84%

90 DAY RETURN

+21.39%

ASX RANK

431

/2,032

SECTOR RANK

1

/9

SHARES OUTSTANDING

142.61m
ASX:GSS

GENETIC SIGNATURES LIMITED

Health Care

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Market Cap

323.73m

Price at Close

$2.27

4w avg. Volume

233.73k

4w avg. Turnover

$591.10k

ASX:GSS is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

(03) 9028 2888

deals@freshequities.com

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.